切换至 "中华医学电子期刊资源库"

中华细胞与干细胞杂志(电子版) ›› 2020, Vol. 10 ›› Issue (04) : 195 -203. doi: 10.3877/cma.j.issn.2095-1221.2020.04.001

所属专题: 文献

论著

人间充质干细胞对乳腺癌细胞生长的影响研究
杨园园1, 朱新贤1, 靳霞1, 童晓文1,()   
  1. 1. 200065 上海,同济大学附属同济医院妇产科
  • 收稿日期:2019-09-07 出版日期:2020-08-01
  • 通信作者: 童晓文
  • 基金资助:
    国家自然科学基金(81702745)

Effects of human mesenchymalstem cells on the growth of breast cancer cells

Yuanyuan Yang1, Xinxian Zhu1, Xia Jin1, Xiaowen Tong1,()   

  1. 1. Department of Obstetrics and Gynecology, Tongji Hospital Affiliated to Tongji University, Shanghai 200065, China
  • Received:2019-09-07 Published:2020-08-01
  • Corresponding author: Xiaowen Tong
  • About author:
    Corresponding author: Tong Xiaowen, Email:
引用本文:

杨园园, 朱新贤, 靳霞, 童晓文. 人间充质干细胞对乳腺癌细胞生长的影响研究[J/OL]. 中华细胞与干细胞杂志(电子版), 2020, 10(04): 195-203.

Yuanyuan Yang, Xinxian Zhu, Xia Jin, Xiaowen Tong. Effects of human mesenchymalstem cells on the growth of breast cancer cells[J/OL]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2020, 10(04): 195-203.

目的

通过构建间充质干细胞(MSC)与乳腺癌细胞间相互作用的共培养模型,探讨MSC对乳腺癌细胞生长的影响。

方法

用含荧光基因第三代自身失活慢病毒载体感染人类脐带分离提取的MSC和乳腺癌细胞MDA-MB-231、MCF-7,以单独培养的乳腺癌细胞MDA-MB-231和MCF-7分别设立对照,2种乳腺癌细胞分别与MSC共培养,检测乳腺癌细胞在MSC作用下增生能力的改变,流式细胞术检测共培养后细胞表面标记物表达。两组间比较采用独立样本t检验,多组间比较采用单因素方差分析,多重比较采用Dunnet-t检验。

结果

MSC在与乳腺癌细胞共培养过程中促进肿瘤细胞生长,第3天共培养组乳腺癌MDA-MB-231细胞数高于单独MDA-MB-231培养组[(5.50±0.71)×103个比(1.63±0.41)×103个],培养至第7天,两组间MDA-MB-231细胞数差异进一步增大[(81.25±7.40)×103个比(26.25±4.15)× 103个],差异具有统计学意义(P均< 0.001);共培养后MSC促进乳腺癌细胞表达干细胞特有标记物CD90,MCF-7从共培养第2天CD90表达率(1.38±0.30)﹪升高至第9天(92.45±2.04)﹪。在共培养中MSC围绕肿瘤细胞集落方式生长,在形态上变长,并发现一种新型混合细胞(hybrid融合细胞)同时表达绿色和红色荧光,且对化疗药物更敏感。

结论

MSC促进乳腺癌细胞的生长,伴随MSC形态学改变和hybrid融合细胞出现,乳腺癌细胞获得MSC特有CD90表达。

Objective

To investigate the effect of MSCs on the growth of breast cancer cells by constructing a co-culture model of the interaction between MSCs and breast cancer cells.

Methods

Human umbilical cord was infected with the third generation of sin lentivirus vector containing fluorescent gene, and then MSCs and breast cancer cells MDA-MB-231, MCF-7 were extracted. Breast cancer cells MDA-MB-231 and MCF-7 were cultured respectively, and then control groups were established. Two breast cancer cells were co-cultured with MSCs respectively, to detect the change of proliferation ability of breast cancer cells under the effect of MSCs. Flow cytometry (FACS) was used to detect the expression of cell surface markers. Independent sample t-test was used for comparison between two groups, one-way ANOVA was used for comparison between multiple groups, and Dunnet-t test was used for multiple comparisons.

Results

MSCs promote tumor cell growth during co-culture with breast cancer cells. After 3 days co-cultre, the number of MDA-MB-231 cells in the co-culture group was significantly higher than that in the single MDA-MB-231 culture group (5.50 ± 0.71) × 103 vs (1.63 ± 0.41) × 103. The difference became more significantly at 7 days co-culture (81.25 ± 7.40) × 103 vs (26.25 ± 4.15) × 103 (P < 0.001) .After co-culture, the expression of stem cell specific marker CD90 could be promoted by MSCs. The expression rate of MCF-7 was only (1.38±0.30) ﹪ at 2 days co-culture and (92.45±2.04) ﹪ at 9 days co-culture. The stem cells grew around the tumor cells and became longer. Meanwhile, a new hybrid cell (hybrid fusion cell) was found, which can simultaneously express green and red fluorescence and was more sensitive to chemotherapeutic drugs.

Conclusion

Human MSCs could promote the growth of breast cancer cells, accompanied by the morphological changes of MSCs and the appearance of hybrid fusion cells. Breast cancer cells could express CD90 and only in MSCs.

图1 荧光显微镜下观察转染前后MSC、乳腺癌细胞MDA-MB-231及MCF-7细胞形态(荧光蛋白染色,×100)
图2 流式细胞仪检测转染前后MSC、乳腺癌细胞MDA-MB-231及MCF-7细胞周期(DAPI染色)
图3 荧光显微镜下观察乳腺癌细胞MCF-7+MSC形态(荧光蛋白染色,×100)
图4 荧光显微镜下观察乳腺癌细胞MDA-MB-231+MSC形态(荧光蛋白染色,×100)
图5 荧光显微镜下观察MCF-7Cherry和MSCGFP,MDA-MB-231Cherry和MSCGFP共培养模型细胞形态(荧光蛋白染色,×200)
图6 荧光显微镜下观察MDA-MB-231Cherry+MSCGFP共培养状态下MSC内外泌体分泌情况(荧光蛋白染色,×400)
表1 MDA-MB-231与MSC共培养与单独培养组间细胞增殖能力变化(×103个,±sn = 4)
表2 MCF-7与MSC共培养与单独培养组间增殖能力变化(×103个,±sn = 4)
图7 FACS分析细胞周期比例变化
图8 MDA-MB-231与MSC共培养后生成的hybrids融合细胞对不同化疗药物不同浓度作用24、48、72 h的反应效果
1
Melzer C, Rehn V, Yang Y, et al. Taxol-loaded MSC-derived exosomes provide a therapeutic vehicle to target metastatic breast cancer and other carcinoma cells[J]. Cancers (Basel), 2019, 9:11(6):798.
2
Hass R, von der Ohe J, Ungefroren H. Potential role of MSC/cancer cell fusion and EMT for breast cancer stem cell formation[J]. Cancers (Basel), 2019, 25:11(10):1432.
3
Melzer C, von der Ohe J, Otterbein H, et al. Changes in uPA, PAI-1, and TGF-βproduction during breast cancer cell interaction with human mesenchymal stroma/stem-like cells (MSC)[J].Int J Mol Sci, 2019, 20(11):2630.
4
Mohr A, Zwacka R. The future of mesenchymal stem cell-based therapeutic approaches for cancer From cells to ghosts[J].Cancer Lett, 2018, 414:239-249.
5
Patel S, Alam A, Pant R, et al.Wnt signaling and its significance within the tumor microenvironment: novel therapeutic insights[J]. Front Immunol, 2019, 10:2872.
6
De Miguel MP, Fuentes-Julián S, Blázquez-Martínez A, et al. Immunosuppressive properties of mesenchymal stem cells: advances and applications[J]. Curr Mol Med, 2012, 12(5):574-591.
7
曲泽澎,贾兆锋,黄曦, 等. 间充质干细胞在器官移植中的应用研究进展[J]. 器官移植, 2018, 9(5):348-353.
8
Kachgal S, Putnam AJ. Mesenchymal stem cells from adipose and bone marrow promote angiogenesis via distinct cytokine and protease expression mechanisms[J]. Angiogenesis, 2011, 14(1):47-59.
9
Guido M, James AA, Julian K M, et al. Intravascular mesenchymal stromal/stem cell therapy product diversification: time for new clinical guidelines[J]. Trends Mol Med, 2019, 25(2):149-163.
10
Melzer C, von der Ohe J, Hass R. Involvement of actin cytoskeletal components in breast cancer cell fusion with human mesenchymal stroma/stem-like cells[J]. Int J Mol Sci, 2019, 20(4):876.
11
Rust S, Guillard S, Sachsenmeier K, et al. Combining phenotypic and proteomic approaches to identify membrane targets in a 'triple negative' breast cancer cell type[J]. Mol Cancer, 2013, 12:11.
12
Mandel K, Seidl D, Rades D, et al. Characterization of spontaneous and TGF-β-induced cell motility of primary human normal and neoplastic mammary cells in vitro using novel real-time technology[J]. PLoS One, 2013, 8(2):e56591.
13
Yang Y, Otte A, Hass R. Human mesenchymalstroma/stem cells exchange membrane proteins and alter functionality during interaction with different tumor cell lines[J]. Stem Cells Dev, 2015, 24(10):1205-1222.
14
Sasser AK, Mundy BL, Smith KM, et al. Human bone marrow stromal cells enhance breast cancer cell growth rates in a cell line-dependent manner when evaluated in 3D tumor environments[J]. Cancer Lett, 2007, 254(2):255-264.
15
Sosnoski DM, Krishnan V, Kraemer WJ, et al. Changes in cytokines of the bone microenvironment during breast cancer metastasis[J]. Int J Breast Cancer, 2012, 2012:160265.
16
Hass R, Jennek S, Yang Y, et al. c-Met expression and activity in urogenital cancers-novel aspects of signal transduction and medical implications[J]. Cell Commun Signal, 2017, 15(1):10.
17
Otte A, Yang Y, von der OheJ,et al.SCCOHT tumors acquire chemoresistance and protection by interacting mesenchymalstroma/stem cells within the tumor microenvironment[J]. Int J Oncol, 2016, 49(6):2453-2463.
[1] 洪玮, 叶细容, 刘枝红, 杨银凤, 吕志红. 超声影像组学联合临床病理特征预测乳腺癌新辅助化疗完全病理缓解的价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 571-579.
[2] 刘伟, 牛云峰, 安杰. LINC01232 通过miR-516a-5p/BCL9 轴促进三阴性乳腺癌的恶性进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 330-338.
[3] 涂盛楠, 胡芬, 张娟, 蔡海峰, 杨俊泉. 天然植物提取物在乳腺癌治疗中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 366-370.
[4] 张钊, 骆成玉, 张树琦, 何平, 李旭斌. 不同术式治疗早期乳腺癌的效果及并发症发生率、复发率比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 494-497.
[5] 宋佳, 汪波, 孙凯律, 商江峰, 吴旦平, 肇毅. 吲哚菁绿荧光显影联合亚甲蓝染色在乳腺癌前哨淋巴结活检中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 498-501.
[6] 孙建娜, 孔令军, 任崇禧, 穆坤, 王晓蕊. 266例首诊Ⅳ期乳腺癌手术患者预后分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 502-505.
[7] 唐丹萍, 王萍, 江孟蝶, 杨晓蓉. 自体脂肪移植在乳腺癌术后乳房重建的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 582-585.
[8] 祝炜安, 林华慧, 吴建杰, 黄炯煅, 吴婷婷, 赖文杰. RDM1通过CDK4促进前列腺癌细胞进展的研究[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 618-625.
[9] 傅红兴, 王植楷, 谢贵林, 蔡娟娟, 杨威, 严盛. 间充质干细胞促进胰岛移植效果的研究进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 351-360.
[10] 王大伟, 陆雅斐, 皇甫少华, 陈玉婷, 陈澳, 江滨. 间充质干细胞通过调控免疫机制促进创面愈合的研究进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 361-366.
[11] 袁园园, 岳乐淇, 张华兴, 武艳, 李全海. 间充质干细胞在呼吸系统疾病模型中肺组织分布及治疗机制的研究进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 374-381.
[12] 刘琦, 王守凯, 王帅, 苏雨晴, 马壮, 陈海军, 司丕蕾. 乳腺癌肿瘤内微生物组的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 841-845.
[13] 王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
[14] 王帅, 张志远, 苏雨晴, 李雯雯, 王守凯, 刘琦, 李文涛. 孟德尔随机化及其在乳腺癌研究中的应用进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 671-676.
[15] 崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
阅读次数
全文


摘要